Carna Biosciences, Inc. Logo

Carna Biosciences, Inc.

4572 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
神戸市中央区港島南町一丁目5番5号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Carna Biosciences, Inc. is a Japanese biotechnology company focused on drug discovery and development, specializing in the fields of protein kinases and cellular signaling pathways. The company is renowned for its innovative solutions in biomarker discovery and assay development, serving pharmaceutical and biotechnology companies in their quest for novel therapeutics. Carna's proprietary technology platforms enable high-throughput screening and in-depth characterization of kinase activities, facilitating the identification of potential drug candidates. With a commitment to advancing precision medicine, Carna Biosciences plays a vital role in enhancing the efficiency of drug development processes while contributing to breakthroughs in cancer and other diseases.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Carna Biosciences, Inc.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-11 08:47
Prospectus
有価証券届出書(組込方式)
Japanese 393.6 KB
2025-07-11 08:46
Prospectus
有価証券届出書(組込方式)
Japanese 393.6 KB
2025-07-11 08:45
Prospectus
有価証券届出書(組込方式)
Japanese 392.8 KB
2025-03-28 02:41
Regulatory News Service
臨時報告書
Japanese 28.5 KB
2025-03-26 02:11
Regulatory News Service
内部統制報告書-第22期(2024/01/01-2024/12/31)
Japanese 24.5 KB
2025-03-26 02:10
Regulatory News Service
確認書
Japanese 8.7 KB
2025-03-26 02:08
Annual Report
有価証券報告書-第22期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2024-09-25 08:39
Regulatory News Service
臨時報告書
Japanese 122.5 KB
2024-08-08 02:51
Regulatory News Service
確認書
Japanese 8.7 KB
2024-08-08 02:50
Interim Report
半期報告書-第22期(2024/01/01-2024/12/31)
Japanese 213.7 KB
2024-05-15 09:51
Regulatory News Service
臨時報告書
Japanese 114.0 KB
2024-05-13 02:38
Regulatory News Service
確認書
Japanese 8.7 KB
2024-05-13 02:37
Quarterly Report
四半期報告書-第22期第1四半期(2024/01/01-2024/03/31)
Japanese 173.9 KB
2024-03-28 08:47
Regulatory News Service
臨時報告書
Japanese 30.1 KB
2024-03-27 02:59
Regulatory News Service
内部統制報告書-第21期(2023/01/01-2023/12/31)
Japanese 24.5 KB

Automate Your Workflow. Get a real-time feed of all Carna Biosciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Carna Biosciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK